MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Vor Biopharma Inc. (VOR)

Vor Biopharma Inc. (VOR)

|||

Balance Sheets Overview

Current Ratio
1914.67%
Quick Ratio
1914.67%
Cash Ratio
434.65%
Debt to Asset Ratio
141.62%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Prepaid expenses
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Warrant liabilities
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
107,855
169,873
396,486
160,462
Marketable securities
358,274
321,652
58,722
10,000
Prepaid expenses
5,875
6,394
1,152
747
Other current assets
3,103
2,859
1,745
1,277
Total current assets
475,107
500,778
458,105
172,486
Restricted cash
168
168
168
168
Property and equipment, net
648
565
533
271
Operating lease right-of-use assets
2,718
2,827
2,936
3,043
Other assets
2,412
2,408
2,384
269
Total assets
481,053
506,746
464,126
176,237
Accounts payable
3,998
1,043
5,127
885
Accrued liabilities
20,481
14,727
19,764
17,702
Operating lease liabilities
335
307
280
252
Total current liabilities
24,814
16,077
25,171
18,839
Operating lease liabilities, less current portion
2,542
2,632
2,720
2,807
Warrant liabilities
653,894
638,461
600,547
2,380,078
Total liabilities
681,250
657,170
628,438
2,401,724
Common stock, 0.0001 par value 800,000,000 and 400,000,000 shares authorized as of june 30, 2026 and december 31, 2025, respectively 54,455,751 and 38,720,196 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
19
19
18
15
Additional paid-in capital
1,236,073
1,222,823
988,604
650,319
Accumulated other comprehensive (loss) income
-922
-706
41
12
Accumulated deficit
-1,435,367
-1,372,560
-1,152,975
-2,875,833
Total stockholders' deficit
-200,197
-150,424
-164,312
-2,225,487
Total liabilities and stockholders' deficit
481,053
506,746
464,126
176,237
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$358,274K (3485.97%↑ Y/Y)Cash and cashequivalents$107,855K (-43.41%↓ Y/Y)Prepaid expenses$5,875K (291.67%↑ Y/Y)Other current assets$3,103K (591.09%↑ Y/Y)Total current assets$475,107K (131.84%↑ Y/Y)Operating leaseright-of-use assets$2,718K (11225.00%↑ Y/Y)Other assets$2,412K (474.29%↑ Y/Y)Property and equipment,net$648K Restricted cash$168K Total assets$481,053K (134.24%↑ Y/Y)Accumulated deficit-$1,435,367K (30.43%↑ Y/Y)Accumulated othercomprehensive (loss) income-$922K (-6685.71%↓ Y/Y)Total liabilities andstockholders' deficit$481,053K (134.24%↑ Y/Y)Total stockholders'deficit-$200,197K (86.70%↑ Y/Y)Additional paid-in capital$1,236,073K (121.75%↑ Y/Y)Common stock, 0.0001par value...$19K (46.15%↑ Y/Y)Total liabilities$681,250K (-60.19%↓ Y/Y)Warrant liabilities$653,894K (-60.43%↓ Y/Y)Total currentliabilities$24,814K (-57.78%↓ Y/Y)Operating leaseliabilities, less current...$2,542K Accrued liabilities$20,481K (-64.75%↓ Y/Y)Accounts payable$3,998K (497.61%↑ Y/Y)Operating leaseliabilities$335K